Stay updated on Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page
- ChecktodayChange DetectedThe site footer revision label changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe clinical trial record for KEYNOTE-122 is available, detailing its comparison of pembrolizumab with standard chemotherapy for recurrent or metastatic nasopharyngeal cancer. It includes participant eligibility, treatment arms, measured outcomes, and study publications.SummaryDifference60%

- Check21 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check28 days agoChange DetectedA site-wide banner announces NIH updates and says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check35 days agoChange DetectedThe ClinicalTrials.gov error page’s footer revision number was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check42 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page.